| Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing C Kanellopoulou, SA Muljo, AL Kung, S Ganesan, R Drapkin, T Jenuwein, ... Genes & development 19 (4), 489-501, 2005 | 1609 | 2005 |
| Whole–genome characterization of chemoresistant ovarian cancer AM Patch, EL Christie, D Etemadmoghadam, DW Garsed, J George, ... Nature 521 (7553), 489-494, 2015 | 1544 | 2015 |
| Rethinking ovarian cancer: recommendations for improving outcomes S Vaughan, JI Coward, RC Bast Jr, A Berchuck, JS Berek, JD Brenton, ... Nature Reviews Cancer 11 (10), 719-725, 2011 | 1532 | 2011 |
| Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer DD Bowtell, S Böhm, AA Ahmed, PJ Aspuria, RC Bast Jr, V Beral, ... Nature reviews Cancer 15 (11), 668-679, 2015 | 1203 | 2015 |
| A candidate precursor to serous carcinoma that originates in the distal fallopian tube Y Lee, A Miron, R Drapkin, MR Nucci, F Medeiros, A Saleemuddin, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2007 | 1079 | 2007 |
| 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers P Bouwman, A Aly, JM Escandell, M Pieterse, J Bartkova, ... Nature structural & molecular biology 17 (6), 688-695, 2010 | 1078 | 2010 |
| Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas R Drapkin, HH Von Horsten, Y Lin, SC Mok, CP Crum, WR Welch, ... Cancer research 65 (6), 2162-2169, 2005 | 931 | 2005 |
| The ubiquitin ligase activity in the DDB2 and CSA complexes is differentially regulated by the COP9 signalosome in response to DNA damage R Groisman, J Polanowska, I Kuraoka, J Sawada, M Saijo, R Drapkin, ... Cell 113 (3), 357-367, 2003 | 888 | 2003 |
| BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function SB Cantor, DW Bell, S Ganesan, EM Kass, R Drapkin, S Grossman, ... Cell 105 (1), 149-160, 2001 | 865 | 2001 |
| High grade serous ovarian carcinomas originate in the fallopian tube SI Labidi-Galy, E Papp, D Hallberg, N Niknafs, V Adleff, M Noe, ... Nature communications 8 (1), 1093, 2017 | 710 | 2017 |
| Prognostically relevant gene signatures of high-grade serous ovarian carcinoma RGW Verhaak, P Tamayo, JY Yang, D Hubbard, H Zhang, CJ Creighton, ... The Journal of clinical investigation 123 (1), 2012 | 658 | 2012 |
| Pretreatment mitochondrial priming correlates with clinical response to cytotoxic chemotherapy TN Chonghaile, KA Sarosiek, TT Vo, JA Ryan, A Tammareddi, ... Science 334 (6059), 1129-1133, 2011 | 645 | 2011 |
| Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca; Tp53; Pten models R Perets, GA Wyant, KW Muto, JG Bijron, BB Poole, KT Chin, JYH Chen, ... Cancer cell 24 (6), 751-765, 2013 | 622 | 2013 |
| The distal fallopian tube: a new model for pelvic serous carcinogenesis CP Crum, R Drapkin, A Miron, TA Ince, M Muto, DW Kindelberger, Y Lee Current Opinion in Obstetrics and Gynecology 19 (1), 3-9, 2007 | 605 | 2007 |
| Dual role of TFIIH in DNA excision repair and in transcription by RNA polymerase II R Drapkin, JT Reardon, A Ansari, JC Huang, L Zawel, KJ Ahn, A Sancar, ... Nature 368 (6473), 769-772, 1994 | 598 | 1994 |
| A recurrent mutation in PALB2 in Finnish cancer families H Erkko, B Xia, J Nikkilä, J Schleutker, K Syrjäkoski, A Mannermaa, ... Nature 446 (7133), 316-319, 2007 | 573 | 2007 |
| Cdk-activating kinase complex is a component of human transcription factor TFIIH R Shiekhattar, F Mermelstein, RP Fisher, R Drapkin, B Dynlacht, ... Nature 374 (6519), 283-287, 1995 | 546 | 1995 |
| Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer HW Cheung, GS Cowley, BA Weir, JS Boehm, S Rusin, JA Scott, A East, ... Proceedings of the National Academy of Sciences 108 (30), 12372-12377, 2011 | 513 | 2011 |
| New insights into the pathogenesis of serous ovarian cancer and its clinical impact K Levanon, C Crum, R Drapkin Journal of Clinical Oncology 26 (32), 5284-5293, 2008 | 512 | 2008 |
| A comprehensive analysis of PAX8 expression in human epithelial tumors AR Laury, R Perets, H Piao, JF Krane, JA Barletta, C French, LR Chirieac, ... The American journal of surgical pathology 35 (6), 816-826, 2011 | 482 | 2011 |
Michelle HirschBrigham and Women's Hospital, Harvard Medical School在 bwh.harvard.edu 的电子邮件经过验证
